Search results
GSK's Blenrep Combo Therapy Cuts Risk Of Disease Progression Or Death By Around 50% In Pretreated...
Benzinga via Yahoo Finance· 5 days agoThe data were presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting. On...
GSK blood cancer drug nearly halves risk of death in late-stage trial
Reuters via Yahoo News· 7 days agoIn the trial of 302 patients with relapsed or difficult-to-treat multiple myeloma, 71% of those who...
POEMS Syndrome
Health via Yahoo News· 2 days agoChemotherapy involves the use of drugs (without radiation) to target and kill cancer cells. Chemotherapy treatment regimens to treat POEMS syndromes...
Adding Isatuximab to Standard Backbone Improves Outcomes in Multiple Myeloma
MedPage Today· 5 days agoTwo trials show positive outcomes
Biotech Stock Roundup: GSK's Litigation Update, BIIB's Drug Approval & Other Updates
Zacks via Yahoo Finance· 2 days agoThe trial is evaluating Blenrep (belantamab mafodotin), in combination with pomalidomide plus...
DARZALEX® (daratumumab)-based regimens significantly improve clinical outcomes in both...
Valley City Times Record· 5 days agoThe...
AbbVie treats first subject in Phase III multiple myeloma drug trial
Clinical Trials Arena via Yahoo Finance· 3 days agoThe SAT options include combinations of carfilzomib and dexamethasone, elotuzumab with pomalidomide...
Cancer-fighting antibodies inject chemo directly into tumor cells, upping effectiveness
NBC NEWS· 7 days agoThe chemotherapy-antibody combinations, known as antibody drug conjugates, have been described as...
AbbVie (ABBV) Starts Late-Stage Study on Multiple Myeloma Drug
Zacks via Yahoo Finance· 3 days agoThe late-stage study will evaluate AbbVie's (ABBV) experimental antibody to treat patients with...
Tip Sheet: Breast cancer guidelines change again, | Newswise
Newswise· 4 days agoBelow are summaries of recent Fred Hutchinson Cancer Center research findings and other news. March is Colorectal Cancer Awareness Month, contact our media
